TITLE
Cirrhotic liver response to the antiangiongenic agent Sunitinib

SUMMARY
Analysis of cirrhotic livers from animals treated with antioangeogenic agent Sunitinib. In cirrhosis, pathological processes such as inflammation and pathological angiogenesis are closely integrated. Results provide insight into the utility of targeting angiogenesis in the treatment of cirrhosis.

ORGANISM
Rattus norvegicus

PLATFORM
GPL1355 : [Rat230_2] Affymetrix Rat Genome 230 2.0 Array

CITATIONS
Tugues S, Fernandez-Varo G, Muñoz-Luque J, Ros J et al. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 2007 Dec;46(6):1919-26. PMID:  17935226

